Hanmi becomes pharma having the highest No. of overseas new drug pipelines

Published: 2017-02-22 14:26:13

Updated: 2017-02-23 13:08:45

It was observed Hanmi Pharm was the Korean pharmaceutical company which has the highest number of new drug pipelines in progress of overseas clinical trial.

According to the status of Korean pharmaceutical companies’ new drug pipelines, conducted by SK Securities, Hanmi Pharm is carrying out 6 new drug pipelines in other countries, such as the ongoing U.S. Phase 2 clinical trial of the company...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.